Combined ganciclovir and foscarnet in pediatric cytomegalovirus retinitis

Journal of the National Medical Association

Volumn 88, Issue 10, 1996, Pages 661-662

  Sastry, Srinivas M ^a,b   Epps III, Charles H ^a   Walton, R Christopher ^a   Rana, Soheil N ^a   Sanders, Reginald J ^a  

^a Box 356485 ^*

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Acquired immunodeficiency syndrome (AIDS); Cytomegalovirus; Retinitis

Indexed keywords

ENZYME INHIBITOR; FOSCARNET; GANCICLOVIR;

ARTICLE; CASE REPORT; DRUG COMBINATION; FEMALE; HUMAN; PRESCHOOL CHILD; RETINITIS;

CHILD, PRESCHOOL; CYTOMEGALOVIRUS RETINITIS; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; FEMALE; FOSCARNET; GANCICLOVIR; HUMANS;

EID: 0030266433     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Dennehy PJ, Warman R, Flynn JT, Scott GB, Mastrucci MT. Ocular manifestations in pediatric patients with acquired immunodeficiency syndrome. Arch Ophthalmol. 1989;107:978-982.
2. Butler KM, De Smet MD, Husson RN, Mueller B, Manjunath K, Montrella K, et al. Treatment of aggressive cytomegalovirus retinitis with ganciclovir in combination with foscarnet in child with human immunodeficiency virus. J Pediatr. 1992;120:483-486.
3. Studies of Ocular Complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med. 1992;326:213-220.
4. Flores-Aguilar M, Kuppermann BD, Quiceno JI, Dankar WM, Wolf DG, Cpparelli EV, et al. Pathophysiology and treatment of clinically resistant cytomegalovirus retinitis. Ophthalmology. 1993;100:1022-1031.
5. Jacobson MA, Kramer F, Bassiakos Y, Hooton T, Polsky B, Geheb H, et al. Randomized phase I trial of two different combination foscarnet and ganciclovir chronic maintenance therapy regimens for AIDS patients with cytomegalovirus retinitis: AIDS clinical trials group protocol 151. J Infect Dis. 1994;170:189-193.